Alnylam Pharmaceuticals Inc. (ALNY)

Market is closed
Insider Trading: Purchases
Insider Price Amount Relationship Remaining Holdings Date Form 4
$71.87 297,501 Large Shareholder 10,554,134 2017-05-31 Filing
$65.35 11,500 Officer 11,500 2017-05-30 Filing
$37.00 27,900 Director 27,900 2016-10-13 Filing
$58.36 2,000 Director 4,000 2016-03-09 Filing
$69.75 205,030 Large Shareholder 10,256,633 2016-02-01 Filing
$112.16 2,000 Director 2,000 2015-05-12 Filing
$95.00 97,118 Large Shareholder 10,051,603 2015-01-29 Filing
$93.17 196,251 Large Shareholder 9,307,037 2015-01-22 Filing
$95.00 10,000 Officer, Director 122,825 2015-01-26 Filing
$95.00 1,000 Director 1,000 2015-01-26 Filing
$95.00 647,448 Large Shareholder 9,954,485 2015-01-26 Filing
$9,317.00 196,251 Large Shareholder 9,307,037 2015-01-22 Filing
$66.88 344,448 Large Shareholder 9,110,786 2014-03-25 Filing
$20.13 4,967 Director 14,269 2013-01-22 Filing
$10.75 9,302 Director 9,302 2012-02-21 Filing
$10.75 93,023 Director 252,111 2012-02-21 Filing
$10.75 10,000 Director 10,000 2012-02-21 Filing
$10.75 930 Officer 11,681 2012-02-21 Filing
$10.75 1,860 Officer 4,572 2012-02-21 Filing
$10.75 5,581 Officer, Director 58,503 2012-02-21 Filing